For the past 12 years, Hans Detlef Klueber, Basel, Switzerland first acted as 'midwife' and then sustained of this latter connection with the Springer Publishing Company. We owe him much for his diligence and dedication.
Some exceptional research reports and reviews were to follow over the years. If downloads and citations are any guide to a journal's success, then Table 3 in the accompanying article by Kim Rainsford highlights some relevant data. The Journal now has a citation index of 2.304.
Looking to the future-and perhaps a golden jubilee in 2041-we may well wonder if print/electronic/? other forms of publishing will be used to meet the needs of future researchers who need to know what are still the favoured drugs/hormones to control Pain, Inflammation, Tissue Healing; perhaps together with novel approaches to treating, these aberrations from normal homeostasis with yet other strategies-of which we can only dream at present. For example, who would have guessed as recently as 5 years ago that faecal transplants might now be routinely used to down-regulate some forms of chronic bowel inflammation by re-adjusting the intestinal microbiome. Other innovative medico-surgical practises are certainly sure to follow, taking our focus from synthetic chemicals, natural products or engineered proteins/polynucleotides to re-adjusting the 'norm' by other strategies relevant to that individual's constitution and environmental exposure(s). The remarkable saga of insult and adaption that we call 'Inflammation' will probably still be central to the Journal's focus upon the basis of health and wellbeing.
Floreat IPH. Editorial Consultant (1990-) . Whitehouse whitehousemd@bigpond.com This Journal has published reports about the properties and potential of anti-microbial silver pharmaceuticals for controlling experimental inflammation (Whitehouse et al. 2013 ) and pro-arthritic bacteria (Disannayake et al. 2014) . It has previously published clinical reports about the antiinflammatory properties of silver's two companion metals in Group 11 of the Periodic Table, namely, copper (Weiping et al. 1997 ) and gold (Kean and Kean 2008) . Before there were any scientific publications in European languages, these other two noble/coinage metals (along with silver) had long histories of use in medicine (Whitehouse 2015a). Therefore, one challenge presented in, and following, the Silver Anniversary of Inflammopharmacology is to establish some boundaries for the safe use of silver pharmaca, such as for treating/preventing chronic inflammatory disorders, e.g., rheumatoid arthritis, ankylosing spondylitis, multiple sclerosis, etc., that may be initiated or sustained by microbial infection (Whitehouse 2015b) .
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